<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EDAC6956-BD23-4B16-A231-C6FEFA5F4965"><gtr:id>EDAC6956-BD23-4B16-A231-C6FEFA5F4965</gtr:id><gtr:name>Pain Relief Foundation</gtr:name><gtr:address><gtr:line1>Pain Research Institute</gtr:line1><gtr:line2>Clinical Sciences Centre</gtr:line2><gtr:line3>Lower Lane</gtr:line3><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L9 7AL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/816D8B23-D406-4FA1-AFCC-BE6EDBF45B2F"><gtr:id>816D8B23-D406-4FA1-AFCC-BE6EDBF45B2F</gtr:id><gtr:name>Crohn's in Childhood Research Association (CICRA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7D7664F9-37C1-4C2F-AE3E-27F41EB8BAF5"><gtr:id>7D7664F9-37C1-4C2F-AE3E-27F41EB8BAF5</gtr:id><gtr:name>Ironwood Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/49C44558-A75A-448F-9BF7-3F947FA67EB7"><gtr:id>49C44558-A75A-448F-9BF7-3F947FA67EB7</gtr:id><gtr:name>Technical University of Munich</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDAC6956-BD23-4B16-A231-C6FEFA5F4965"><gtr:id>EDAC6956-BD23-4B16-A231-C6FEFA5F4965</gtr:id><gtr:name>Pain Relief Foundation</gtr:name><gtr:address><gtr:line1>Pain Research Institute</gtr:line1><gtr:line2>Clinical Sciences Centre</gtr:line2><gtr:line3>Lower Lane</gtr:line3><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L9 7AL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/816D8B23-D406-4FA1-AFCC-BE6EDBF45B2F"><gtr:id>816D8B23-D406-4FA1-AFCC-BE6EDBF45B2F</gtr:id><gtr:name>Crohn's in Childhood Research Association (CICRA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7D7664F9-37C1-4C2F-AE3E-27F41EB8BAF5"><gtr:id>7D7664F9-37C1-4C2F-AE3E-27F41EB8BAF5</gtr:id><gtr:name>Ironwood Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/49C44558-A75A-448F-9BF7-3F947FA67EB7"><gtr:id>49C44558-A75A-448F-9BF7-3F947FA67EB7</gtr:id><gtr:name>Technical University of Munich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F93E20E6-1487-4763-8EDE-5DF4F4F47D75"><gtr:id>F93E20E6-1487-4763-8EDE-5DF4F4F47D75</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Colin</gtr:otherNames><gtr:surname>Bulmer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900907"><gtr:id>3DD77302-4B57-4A1B-9BA2-C5D02356A121</gtr:id><gtr:title>Strategic Skills Award</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900907</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-05-17</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>232112</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Munich</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Human Biology</gtr:department><gtr:description>IPODD: intestinal proteases opportunities for drug discovery</gtr:description><gtr:id>2B148D9C-96AE-465D-AFA8-2C748EA8B7CA</gtr:id><gtr:impact>The project is part of a framework 7 program grant funded by the European comission.
Final reports have been completed for this work
The consortium was multi-disciplinary consisting of neuroscientists, immunologists, geneticists, gastroenterologists, microbiologists and pharmacologists from labs across the european union</gtr:impact><gtr:outcomeId>pie5R1djwW4-2</gtr:outcomeId><gtr:partnerContribution>Evaluation of tool molecules (PAR-2 antagonists)Evaluation of tool molecules (PAR-2 antagonists)
Ongoing evaluation of the effects of matrix metalloproteinases on the function of human enteric neuronesEvaluated the effects of PAR-2 antagonists and matrix metalloproteinase inhibitors in animal models of colitis. Technical support to establish in vitro and in vivo assays/ models of intestinal inflammation. Provide samples of supernatant from cultured probiotics.</gtr:partnerContribution><gtr:piContribution>Identification of tool PAR-2 antagonists from patent literature and synthesis of molecules
Established animal models of colitis and examined the effect of matrix metalloproteinase inhibitors
Established in vitro assays to examine the antiinflammatory effects of supernatants from probiotic cultures.
Evaluation of the effects of matrix metalloproteinases on PAR activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Genetics of visceral pain</gtr:description><gtr:id>F6228540-3771-4E43-891F-757C1A9576BB</gtr:id><gtr:impact>Multidisciplinary team of Neuroscientists, Gastroenterologists, Geneticists
Manuscript published</gtr:impact><gtr:outcomeId>J8p9TzGUcgN-1</gtr:outcomeId><gtr:partnerContribution>Research direction
Visceral pain testing in humans
Patient stratification</gtr:partnerContribution><gtr:piContribution>Project management and research direction
Consumable costs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neusentis Pfizer</gtr:department><gtr:description>Role of the voltage gated sodium channel NaV1.9 in visceral pain</gtr:description><gtr:id>01E57BDF-6598-46B5-ABE0-364107433230</gtr:id><gtr:impact>Multi disciplinary team of Neuroscientists, Surgeons, gastroenterologists and industrial scientists.
PhD studentship award (BBSRC case award).
Royal College of Surgeons Fellowship award
Meeting abstracts presented at British Pharmacological Society (2011), United European Gastroenterology Week (2011), World congress on Pain (2012), Neurogastroenterology and Motility (2012).
Manuscripts for publication in preparation.</gtr:impact><gtr:outcomeId>ZD1a4RTDe4X-3</gtr:outcomeId><gtr:partnerContribution>Breeding pairs of NaV1.9 +/- mice
Consumable support (BBSRC CASE award)</gtr:partnerContribution><gtr:piContribution>Consumable and staff costs
Breeding and maintenance of KO mouse colony
Electrophysiological and general lab equipment
Training in electrophysiological recording techniques
Experimental data generation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ironwood Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Development of human electrophysiological visceral afferent recordings</gtr:description><gtr:id>CB3D945E-3856-4A81-B9C0-E93B0BA165C0</gtr:id><gtr:impact>Multidisciplinary collaboration of clinical (surgeons and gastroenterologists) and basic scientist (neusoscientists).
Publication of the first paper detailing electrrophysiological recordings from human visceral afferents.
Follow up work has been presented at the World Congress on Pain 2012, Neurogastroenterology and Motility 2012 and NC3Rs Models of experimental pain meeting. Manuscript currently in preparation.
Grant funding for PhD studentships (Dr Hadwen trust).
Industrial funding received from to further develop the preparation (Neusentis and Ironwood).</gtr:impact><gtr:outcomeId>Er5znD1XBdD-3</gtr:outcomeId><gtr:partnerContribution>Consumable and staff costs.
Supply of human tissue and ethical approval for work on.</gtr:partnerContribution><gtr:piContribution>Equipment, consumable and staff costs, training in electrophysiological techniques, scientific direction.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>IPODD: intestinal proteases opportunities for drug discovery</gtr:description><gtr:id>AEB5FF28-E739-4FEC-9338-164A81E7BB73</gtr:id><gtr:impact>The project is part of a framework 7 program grant funded by the European comission.
Final reports have been completed for this work
The consortium was multi-disciplinary consisting of neuroscientists, immunologists, geneticists, gastroenterologists, microbiologists and pharmacologists from labs across the european union</gtr:impact><gtr:outcomeId>pie5R1djwW4-4</gtr:outcomeId><gtr:partnerContribution>Evaluation of tool molecules (PAR-2 antagonists)Evaluation of tool molecules (PAR-2 antagonists)
Ongoing evaluation of the effects of matrix metalloproteinases on the function of human enteric neuronesEvaluated the effects of PAR-2 antagonists and matrix metalloproteinase inhibitors in animal models of colitis. Technical support to establish in vitro and in vivo assays/ models of intestinal inflammation. Provide samples of supernatant from cultured probiotics.</gtr:partnerContribution><gtr:piContribution>Identification of tool PAR-2 antagonists from patent literature and synthesis of molecules
Established animal models of colitis and examined the effect of matrix metalloproteinase inhibitors
Established in vitro assays to examine the antiinflammatory effects of supernatants from probiotic cultures.
Evaluation of the effects of matrix metalloproteinases on PAR activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Role of the voltage gated sodium channel NaV1.9 in visceral pain</gtr:description><gtr:id>3263677D-A091-456F-ACD3-9CA27FC3FB5D</gtr:id><gtr:impact>Multi disciplinary team of Neuroscientists, Surgeons, gastroenterologists and industrial scientists.
PhD studentship award (BBSRC case award).
Royal College of Surgeons Fellowship award
Meeting abstracts presented at British Pharmacological Society (2011), United European Gastroenterology Week (2011), World congress on Pain (2012), Neurogastroenterology and Motility (2012).
Manuscripts for publication in preparation.</gtr:impact><gtr:outcomeId>ZD1a4RTDe4X-1</gtr:outcomeId><gtr:partnerContribution>Breeding pairs of NaV1.9 +/- mice
Consumable support (BBSRC CASE award)</gtr:partnerContribution><gtr:piContribution>Consumable and staff costs
Breeding and maintenance of KO mouse colony
Electrophysiological and general lab equipment
Training in electrophysiological recording techniques
Experimental data generation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neusentis Pfizer</gtr:department><gtr:description>Development of human electrophysiological visceral afferent recordings</gtr:description><gtr:id>70CCCDAB-69B2-4786-8A2A-BAD5FB31F176</gtr:id><gtr:impact>Multidisciplinary collaboration of clinical (surgeons and gastroenterologists) and basic scientist (neusoscientists).
Publication of the first paper detailing electrrophysiological recordings from human visceral afferents.
Follow up work has been presented at the World Congress on Pain 2012, Neurogastroenterology and Motility 2012 and NC3Rs Models of experimental pain meeting. Manuscript currently in preparation.
Grant funding for PhD studentships (Dr Hadwen trust).
Industrial funding received from to further develop the preparation (Neusentis and Ironwood).</gtr:impact><gtr:outcomeId>Er5znD1XBdD-2</gtr:outcomeId><gtr:partnerContribution>Consumable and staff costs.
Supply of human tissue and ethical approval for work on.</gtr:partnerContribution><gtr:piContribution>Equipment, consumable and staff costs, training in electrophysiological techniques, scientific direction.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neusentis Pfizer</gtr:department><gtr:description>Role of purines in visceral pain</gtr:description><gtr:id>FC95415D-6E46-4825-ADC8-2E9074FE8429</gtr:id><gtr:impact>Publication in Journal of Neuroscience
Meeting abstracts</gtr:impact><gtr:outcomeId>56ceb6c7348da1.55797502-1</gtr:outcomeId><gtr:partnerContribution>Single cell qPCR</gtr:partnerContribution><gtr:piContribution>Electrophysiology
Knock out mice
Human tissue research</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Cork</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Alimentary Pharmabiotic Centre</gtr:department><gtr:description>IPODD: intestinal proteases opportunities for drug discovery</gtr:description><gtr:id>29313081-1CAA-4170-8F2C-45CDC50D97B4</gtr:id><gtr:impact>The project is part of a framework 7 program grant funded by the European comission.
Final reports have been completed for this work
The consortium was multi-disciplinary consisting of neuroscientists, immunologists, geneticists, gastroenterologists, microbiologists and pharmacologists from labs across the european union</gtr:impact><gtr:outcomeId>pie5R1djwW4-5</gtr:outcomeId><gtr:partnerContribution>Evaluation of tool molecules (PAR-2 antagonists)Evaluation of tool molecules (PAR-2 antagonists)
Ongoing evaluation of the effects of matrix metalloproteinases on the function of human enteric neuronesEvaluated the effects of PAR-2 antagonists and matrix metalloproteinase inhibitors in animal models of colitis. Technical support to establish in vitro and in vivo assays/ models of intestinal inflammation. Provide samples of supernatant from cultured probiotics.</gtr:partnerContribution><gtr:piContribution>Identification of tool PAR-2 antagonists from patent literature and synthesis of molecules
Established animal models of colitis and examined the effect of matrix metalloproteinase inhibitors
Established in vitro assays to examine the antiinflammatory effects of supernatants from probiotic cultures.
Evaluation of the effects of matrix metalloproteinases on PAR activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Development of human electrophysiological visceral afferent recordings</gtr:description><gtr:id>B911BAFE-910B-4818-9A3D-4CE50E130085</gtr:id><gtr:impact>Multidisciplinary collaboration of clinical (surgeons and gastroenterologists) and basic scientist (neusoscientists).
Publication of the first paper detailing electrrophysiological recordings from human visceral afferents.
Follow up work has been presented at the World Congress on Pain 2012, Neurogastroenterology and Motility 2012 and NC3Rs Models of experimental pain meeting. Manuscript currently in preparation.
Grant funding for PhD studentships (Dr Hadwen trust).
Industrial funding received from to further develop the preparation (Neusentis and Ironwood).</gtr:impact><gtr:outcomeId>Er5znD1XBdD-1</gtr:outcomeId><gtr:partnerContribution>Consumable and staff costs.
Supply of human tissue and ethical approval for work on.</gtr:partnerContribution><gtr:piContribution>Equipment, consumable and staff costs, training in electrophysiological techniques, scientific direction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Mechanisms of pain in Inflammatory bowel disease</gtr:description><gtr:id>893FE1D1-8A7F-49C4-BC3A-001454AEE453</gtr:id><gtr:impact>Multidisciplinary team of Neuroscientists and Gastroenterologist/Surgeons.
Project has just started</gtr:impact><gtr:outcomeId>KYnYCpDtoMW-2</gtr:outcomeId><gtr:partnerContribution>Clinical support for patient stratification, biopsy and tissue samples, ethics documentation.
Consumable and staff costs</gtr:partnerContribution><gtr:piContribution>Project management
Staff training and equipment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Crohn's in Childhood Research Association (CICRA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mechanisms of pain in Inflammatory bowel disease</gtr:description><gtr:id>2F77D146-F93B-4AC0-A5AD-0AE03E33D1CC</gtr:id><gtr:impact>Multidisciplinary team of Neuroscientists and Gastroenterologist/Surgeons.
Project has just started</gtr:impact><gtr:outcomeId>KYnYCpDtoMW-1</gtr:outcomeId><gtr:partnerContribution>Clinical support for patient stratification, biopsy and tissue samples, ethics documentation.
Consumable and staff costs</gtr:partnerContribution><gtr:piContribution>Project management
Staff training and equipment</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biomedical Science</gtr:department><gtr:description>IPODD: intestinal proteases opportunities for drug discovery</gtr:description><gtr:id>62E86F8D-D088-462B-ADCC-7ED8405CFE70</gtr:id><gtr:impact>The project is part of a framework 7 program grant funded by the European comission.
Final reports have been completed for this work
The consortium was multi-disciplinary consisting of neuroscientists, immunologists, geneticists, gastroenterologists, microbiologists and pharmacologists from labs across the european union</gtr:impact><gtr:outcomeId>pie5R1djwW4-1</gtr:outcomeId><gtr:partnerContribution>Evaluation of tool molecules (PAR-2 antagonists)Evaluation of tool molecules (PAR-2 antagonists)
Ongoing evaluation of the effects of matrix metalloproteinases on the function of human enteric neuronesEvaluated the effects of PAR-2 antagonists and matrix metalloproteinase inhibitors in animal models of colitis. Technical support to establish in vitro and in vivo assays/ models of intestinal inflammation. Provide samples of supernatant from cultured probiotics.</gtr:partnerContribution><gtr:piContribution>Identification of tool PAR-2 antagonists from patent literature and synthesis of molecules
Established animal models of colitis and examined the effect of matrix metalloproteinase inhibitors
Established in vitro assays to examine the antiinflammatory effects of supernatants from probiotic cultures.
Evaluation of the effects of matrix metalloproteinases on PAR activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Role of the voltage gated sodium channel NaV1.9 in visceral pain</gtr:description><gtr:id>4BF29A2D-DFD8-4B63-BB11-0F403FB97BDF</gtr:id><gtr:impact>Multi disciplinary team of Neuroscientists, Surgeons, gastroenterologists and industrial scientists.
PhD studentship award (BBSRC case award).
Royal College of Surgeons Fellowship award
Meeting abstracts presented at British Pharmacological Society (2011), United European Gastroenterology Week (2011), World congress on Pain (2012), Neurogastroenterology and Motility (2012).
Manuscripts for publication in preparation.</gtr:impact><gtr:outcomeId>ZD1a4RTDe4X-2</gtr:outcomeId><gtr:partnerContribution>Breeding pairs of NaV1.9 +/- mice
Consumable support (BBSRC CASE award)</gtr:partnerContribution><gtr:piContribution>Consumable and staff costs
Breeding and maintenance of KO mouse colony
Electrophysiological and general lab equipment
Training in electrophysiological recording techniques
Experimental data generation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pain Relief Foundation</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mechanisms of pain in Inflammatory bowel disease</gtr:description><gtr:id>85A28420-6C08-4E81-B9FB-E8D7CB85D404</gtr:id><gtr:impact>Multidisciplinary team of Neuroscientists and Gastroenterologist/Surgeons.
Project has just started</gtr:impact><gtr:outcomeId>KYnYCpDtoMW-3</gtr:outcomeId><gtr:partnerContribution>Clinical support for patient stratification, biopsy and tissue samples, ethics documentation.
Consumable and staff costs</gtr:partnerContribution><gtr:piContribution>Project management
Staff training and equipment</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Southampton</gtr:department><gtr:description>IPODD: intestinal proteases opportunities for drug discovery</gtr:description><gtr:id>632B8A95-8FA0-4AD4-83C7-085D1187972F</gtr:id><gtr:impact>The project is part of a framework 7 program grant funded by the European comission.
Final reports have been completed for this work
The consortium was multi-disciplinary consisting of neuroscientists, immunologists, geneticists, gastroenterologists, microbiologists and pharmacologists from labs across the european union</gtr:impact><gtr:outcomeId>pie5R1djwW4-3</gtr:outcomeId><gtr:partnerContribution>Evaluation of tool molecules (PAR-2 antagonists)Evaluation of tool molecules (PAR-2 antagonists)
Ongoing evaluation of the effects of matrix metalloproteinases on the function of human enteric neuronesEvaluated the effects of PAR-2 antagonists and matrix metalloproteinase inhibitors in animal models of colitis. Technical support to establish in vitro and in vivo assays/ models of intestinal inflammation. Provide samples of supernatant from cultured probiotics.</gtr:partnerContribution><gtr:piContribution>Identification of tool PAR-2 antagonists from patent literature and synthesis of molecules
Established animal models of colitis and examined the effect of matrix metalloproteinase inhibitors
Established in vitro assays to examine the antiinflammatory effects of supernatants from probiotic cultures.
Evaluation of the effects of matrix metalloproteinases on PAR activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>38000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Bowel &amp; Cancer Research</gtr:fundingOrg><gtr:id>753563E8-A332-436E-9FC3-FD7703A272D4</gtr:id><gtr:outcomeId>sdVHhNmAarS</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small project</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Pain Relief Foundation</gtr:fundingOrg><gtr:id>CBFB35AF-0DE1-44D0-AD09-EA135AA90508</gtr:id><gtr:outcomeId>kb5tHKhqW5r</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small project award</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Crohn's in Childhood Research Association (CICRA)</gtr:fundingOrg><gtr:id>683EF310-5954-4B2A-AB0D-0B13C20B4115</gtr:id><gtr:outcomeId>maAkqapRhQ8</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed an assay to examine the mechanisms underlying the activation of human visceral afferent fibres</gtr:description><gtr:id>FE22648C-F790-426C-B56B-3D9FF01421EE</gtr:id><gtr:impact>Publication of research paper and commentary in GUT</gtr:impact><gtr:outcomeId>s6UHtWuD74Y</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human visceral afferent recordings</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB188B23-7A11-48A8-AA77-6F7E1A51D102</gtr:id><gtr:title>Human visceral afferent recordings: preliminary report.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/095206e87f49051466eff9e26a86c46b"><gtr:id>095206e87f49051466eff9e26a86c46b</gtr:id><gtr:otherNames>Peiris M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>gpT1AZxgGE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B58F444-5878-4223-BEF8-B7F14FBE14D1</gtr:id><gtr:title>P2Y Receptors Sensitize Mouse and Human Colonic Nociceptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f732b742471f31e1acd0ec6bc9ae7"><gtr:id>944f732b742471f31e1acd0ec6bc9ae7</gtr:id><gtr:otherNames>Hockley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56e7ba1e7149c3.88831561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B68CCE2F-8817-4E18-B54A-E877EB1EBB3D</gtr:id><gtr:title>Achieving translation in models of visceral pain.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bdaeffa51ee2c458e1a530b02cd6b2a"><gtr:id>0bdaeffa51ee2c458e1a530b02cd6b2a</gtr:id><gtr:otherNames>Bulmer DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>5a622b6c116e37.88531876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639559C1-563D-44D9-AEFD-94359D724665</gtr:id><gtr:title>The voltage-gated sodium channel NaV 1.9 in visceral pain.</gtr:title><gtr:parentPublicationTitle>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f732b742471f31e1acd0ec6bc9ae7"><gtr:id>944f732b742471f31e1acd0ec6bc9ae7</gtr:id><gtr:otherNames>Hockley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56ceaf6c16eb17.21118039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4569E4A3-9556-40F6-99E6-054C83EF706F</gtr:id><gtr:title>Ex vivo study of human visceral nociceptors.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/352879b3da6470032e7dd117410626ba"><gtr:id>352879b3da6470032e7dd117410626ba</gtr:id><gtr:otherNames>McGuire C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>58b5476eeccd39.95207310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49188142-E9F5-499D-94A8-C5B21384A9EE</gtr:id><gtr:title>Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944f732b742471f31e1acd0ec6bc9ae7"><gtr:id>944f732b742471f31e1acd0ec6bc9ae7</gtr:id><gtr:otherNames>Hockley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>546225354e0456.59714831</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900907</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>